About
Drug discovery & development
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
17
As Collaborator
0
Total Enrollment
2,295
By Phase
NA: 4PHASE2: 5PHASE1: 5PHASE1/PHASE2: 2
By Status
COMPLETED: 10ACTIVE_NOT_RECRUITING: 3ENROLLING_BY_INVITATION: 1TERMINATED: 1UNKNOWN: 1AVAILABLE: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06245031Lead Sponsor
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
NAEnrolling by invitation
402 participants
Started: Feb 29, 2024 · Completed: Mar 31, 2027
NCT05531656Lead Sponsor
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
PHASE2Active, not recruiting
540 participants
Started: Jun 28, 2023 · Completed: Apr 30, 2027
NCT05893537Lead Sponsor
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
PHASE2Terminated
100 participants
Started: Jun 16, 2023 · Completed: Mar 28, 2025
NCT05637801Lead Sponsor
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
NAActive, not recruiting
670 participants
Started: Dec 13, 2022 · Completed: Jul 31, 2026
NCT05225415Lead Sponsor
Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
PHASE2Completed
130 participants
Started: May 19, 2022 · Completed: Nov 25, 2024
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map
Loading map...